Literature DB >> 36105034

Identification of molecular mechanism and key biomarkers in membranous nephropathy by bioinformatics analysis.

Zhaocheng Dong1,2, Yunling Geng1,2, Pingna Zhang1,2, Jingyi Tang1,2, Zijing Cao1,2, Huijuan Zheng1,2, Jing Guo1,2, Chao Zhang1,2, Baoli Liu3, Wei Jing Liu1,2.   

Abstract

OBJECTIVES: Membranous nephropathy (MN) is an autoimmune nephropathy. The incidence of MN is increasing gradually in recent years. Previous studies focused on antibody production, complement activation and podocyte injury in MN. However, the etiology and underlying mechanism of MN remain to be further studied.
METHODS: GSE104948 and GSE108109 of glomerular expression profile were downloaded from Gene Expression Omnibus (GEO) database, GSE47184, GSE99325, GSE104954, GSE108112, GSE133288 of renal tubule expression profile, and GSE73953 of peripheral blood mononuclear cells (PBMCs) expression profile. After data integration by Networkanalyst, differentially expressed genes (DEGs) between MN and healthy samples were obtained. DEGs were enriched in gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG), and protein-protein interaction (PPI) networks of these genes were constructed through Metascape, etc. We further understood the function of hub genes through gene set enrichment analysis (GSEA). The diagnostic value of DEGs in MN was evaluated by receiver operating characteristic (ROC) analysis.
RESULTS: A total of 3 genes (TP53, HDAC5, and SLC2A3) were screened out. Among them, the up-regulated TP53 expression may be closely related to MN renal pathological changes. However, the expression of MN podocyte target antigen was not significantly different from that of healthy controls. In addition, the changes of Wnt signaling pathway in PBMCs and the effects of SLC2A3 on the differentiation of M2 monocyte need further study.
CONCLUSION: It is difficult to unify a specific mechanism for the changes of glomerulus, renal tubules and PBMCs in MN patients. This may be related to the pathogenesis, pathology and immune characteristics of MN. MN podocyte target antigen may not be the root cause of the disease, but a stage result in the pathogenesis process. AJTR
Copyright © 2022.

Entities:  

Keywords:  Membranous nephropathy; integrated bioinformatics; key biomarker; molecular mechanism

Year:  2022        PMID: 36105034      PMCID: PMC9452341     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  75 in total

Review 1.  The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.

Authors:  Anne-Els van de Logt; Maryline Fresquet; Jack F Wetzels; Paul Brenchley
Journal:  Kidney Int       Date:  2019-08-12       Impact factor: 10.612

2.  Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation.

Authors:  Trevor P Fidler; Elizabeth A Middleton; Jesse W Rowley; Luc H Boudreau; Robert A Campbell; Rhonda Souvenir; Trevor Funari; Nicolas Tessandier; Eric Boilard; Andrew S Weyrich; E Dale Abel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-29       Impact factor: 8.311

3.  Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in idiopathic membranous nephropathy.

Authors:  Efthimios Sivridis; Alexandra Giatromanolaki; Stavros Touloupidis; Ploumis Pasadakis; Vasilios Vargemezis
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

4.  NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis.

Authors:  Guangyan Zhou; Othman Soufan; Jessica Ewald; Robert E W Hancock; Niladri Basu; Jianguo Xia
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

5.  Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis.

Authors:  Jiatong Li; Bing Chen; Caifeng Gao; Jing Huang; Yongmei Wang; Shiyin Zhang; Ying Xu; Wenkai Guo; Rong Wang
Journal:  BMC Nephrol       Date:  2019-12-16       Impact factor: 2.388

6.  Screening and Analysis of Key Genes in miRNA-mRNA Regulatory Network of Membranous Nephropathy.

Authors:  Yawei Hou; Yameng Li; Yichuan Wang; Wenpu Li; Zhenwei Xiao
Journal:  J Healthc Eng       Date:  2021-11-16       Impact factor: 2.682

7.  NELL-1 Increased the Osteogenic Differentiation and mRNA Expression of Spheroids Composed of Stem Cells.

Authors:  Jong-Ho Lee; Young-Min Song; Sae-Kyung Min; Hyun-Jin Lee; Hye-Lim Lee; Min-Ji Kim; Yoon-Hee Park; Je-Uk Park; Jun-Beom Park
Journal:  Medicina (Kaunas)       Date:  2021-06-08       Impact factor: 2.430

Review 8.  Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases.

Authors:  Juan Shi; Shuhong Chi; Jing Xue; Jiali Yang; Feng Li; Xiaoming Liu
Journal:  J Immunol Res       Date:  2016-03-27       Impact factor: 4.818

9.  Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy.

Authors:  Jie Hou; Manli Zhang; Yuhong Ding; Xinrui Wang; Tao Li; Pujun Gao; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2018-06-21       Impact factor: 4.711

Review 10.  Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity.

Authors:  Wenbin Liu; Chang Gao; Zhiyuan Liu; Haoran Dai; Zhendong Feng; Zhaocheng Dong; Yang Zheng; Yu Gao; Xuefei Tian; Baoli Liu
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.